Find Academic Supervisors

Vibeke Elisabeth HjortdalView profile

Clinical Professor

• Congenital Heart Diseases
• Cardiopulmonary Physiology
• Exercise Physiology
• +4 more

Vibeke Elisabeth Hjortdal serves as Clinical Professor at the Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, under the Faculty of Health and Medical Sciences at the University of Copenhagen. With a distinguished career spanning several decades, she specializes in congenital heart diseases and has established herself as a leading expert in this specialized field of cardiac medicine. Her academic journey includes earning both a PhD and Doctor of Medical Sciences from Aarhus University, forming the foundation for her extensive research contributions. Professor Hjortdal's research focuses on the pathophysiology of congenital heart diseases, with particular emphasis on the inter-relationship between cardiac and pulmonary function at rest and during exercise, long-term outcomes, lymphatic function in univentricular hearts, and neurodevelopmental outcomes from fetus to adult. Her work employs a translational approach, bridging clinically relevant questions with basic science, clinical projects, and epidemiological studies. This comprehensive methodology has resulted in over 300 peer-reviewed publications and more than 10 textbook chapters, establishing her as a renowned authority in pediatric and congenital cardiac care. Analysis of her recent publications (2024-2025) reveals a strong focus on interdisciplinary approaches to congenital heart disease, spanning cardiology, pulmonology, psychology, and lymphology. Her work increasingly addresses the holistic care of patients, examining not only surgical and physiological aspects but also mental health outcomes, developmental considerations, and quality of life issues. The research demonstrates a clear trajectory toward integrated care models that consider the full spectrum of patient needs throughout their lifespan. Knighted by the Queen of Denmark Member of the Order of the Dannebrog Professor Hjortdal has dedicated significant effort to mentoring the next generation of medical researchers, having supervised numerous DMSc, PhD, and research year students throughout her career. Her teaching commitment extends beyond formal supervision to include more than 50 invited lectures worldwide. Additionally, since 2009, she has engaged in humanitarian work with Chain of Hope (London), where she serves on the Strategic Planning Board, and Gift of Life (New York), performing life-saving surgeries for children with congenital heart diseases in developing countries across the globe. Her international collaborations span numerous countries, reflecting the global impact of her work.

Hiroaki TakahashiView profile

Assistant Professor

• Nuclear Medicine
• Abdominal Imaging
• Prostate Imaging
• +5 more

Hiroaki Takahashi, M.D., Ph.D. is a Nuclear Medicine Specialist Radiologist at Mayo Clinic in Rochester, Minnesota. He serves as a member of the Department of Radiology with active participation in multiple tumor boards including the Adrenal Tumor Board, GYN Tumor Board, and as GU Imaging Liaison for the GU eTumor Board. His professional memberships include the Society of Nuclear Medicine and Molecular Imaging, Society of Abdominal Radiology, Radiological Society of North America, and American Board of Radiology. Dr. Takahashi's research focuses on nuclear medicine, abdominal imaging, and prostate imaging with a strong emphasis on artificial intelligence applications. His work spans multiple clinical areas including endometriosis detection, prostate cancer diagnosis, and upper urinary tract imaging. Recent publications demonstrate his innovative approach to developing MRI scoring systems, improving diagnostic accuracy through deep learning models, and analyzing anatomical structures for better clinical outcomes. Analysis of his recent publications (2024-2025) reveals a strong trend toward integrating artificial intelligence with traditional imaging techniques. His research shows particular emphasis on improving diagnostic accuracy in prostate imaging, developing standardized scoring systems for endometriosis, and applying anatomical knowledge to enhance imaging interpretation. The breadth of his work across multiple clinical specialties demonstrates his versatility as a radiologist and researcher. Certificate of Merit Radiological Society of North America (2024) Cum Laude RSNA (2023) RSNA Diagnosis Please Certificate of Recognition award (2023) Cum Laude RSNA (2022) Certificate of Merit RSNA (2022) Magna Cum Laude RSNA (2021) Itai Award Japan Radiological Society (2020) Certificate of Merit RSNA (2019) Dr. Takahashi maintains an active research program with numerous recent publications, suggesting strong grant support and institutional backing at Mayo Clinic. His collaborations span multiple departments including urology, gynecology, and oncology, indicating a well-integrated research program with clinical applications. His work on AI-assisted diagnostic models represents a growing area of funding interest in medical imaging. While no specific laboratory is mentioned, Dr. Takahashi's research involves collaboration with multiple imaging teams at Mayo Clinic, particularly in abdominal imaging, nuclear medicine, and AI applications. His work with deep learning models for endometriosis detection and prostate cancer diagnosis suggests involvement with computational imaging teams and access to advanced imaging technology at Mayo Clinic.

• Pediatric Hematology/Oncology
• Leukemia/Lymphoma
• Vascular Anomalies
• +4 more

Dr. Richard L. Tower is a Professor of Pediatric Hematology/Oncology/BMT at the Medical College of Wisconsin (MCW), where he also serves as Interim Medical Director of Pediatric Hematology/Oncology/BMT (2024-Present). With over 15 years of academic experience, he has progressed from Assistant Professor (2007-2015) to Associate Professor (2015-2022) to his current full Professor position. Dr. Tower holds multiple leadership roles including Director of the Fellowship Program (2012-Present) and Co-Director of Fellowship Education (2014-Present) at MCW. He is actively involved in national organizations as a member of the Board of Trustees for the American Society of Pediatric Hematology/Oncology (ASPHO) and serves on the Accreditation Appeals Panel for Pediatric Hematology/Oncology at the ACGME. Dr. Tower's research focuses on pediatric leukemia/lymphoma, vascular anomalies, lymphatic system disorders, and medical education in hematology-oncology. His recent work includes multiple chapters in Nelson Textbook of Pediatrics on lymphatic system anatomy and disorders (2024), research on targeted treatments for vascular anomalies (2021), and development of communication skills simulation training for fellowship education (2025). His publications demonstrate expertise across clinical hematology-oncology, medical education, and rare disease management, with work appearing in high-impact journals including Journal of Pediatric Hematology and Oncology, British Journal of Dermatology, and JAMA Dermatology. Dr. Tower has received numerous teaching awards including being named to 'Best Doctors in America' for five consecutive periods (2013-2022) and the 'Expert Teacher' award from Pediatrics (2016). His leadership extends to national medical education initiatives where he has contributed to the development of Entrustable Professional Activities for Pediatric Hematology-Oncology and served on ACGME committees developing milestones for fellowship training. He has mentored over 20 fellows since 2007 and continues to shape the next generation of pediatric hematology-oncology specialists through his educational leadership and research mentorship.

• Health Economics
• Economic Evaluation
• Neglected Tropical Diseases
• +6 more

Dr. Natalia Ivashikina is a Reader in Health Economics at the Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex. She joined the department in December 2017 and has established herself as a leading researcher in economic evaluation of healthcare interventions, particularly for neglected tropical diseases in low- and middle-income countries. Dr. Ivashikina completed her PhD at Moscow State University in 1996, followed by a Royal Society Fellowship in the UK (1997-1998). She then conducted research at Würzburg University, Germany (1999-2005), and completed an MSc in Health and Social Care Research at Sheffield University in 2011. Prior to joining Brighton and Sussex Medical School, she worked at Bangor University (2008-2013) and Queen Mary University of London (2013-2017). Her research focuses on economic evaluation methodologies and their application to neglected tropical diseases (podoconiosis, mycetoma, and scabies), HIV, non-medical prescribing, and neonatal care. Dr. Ivashikina's work spans all aspects of economic evaluations, from systematic literature review to statistical analysis and economic modeling. She has established extensive international collaborations with institutions across Africa and Europe. Her recent publications (2020-2025) demonstrate consistent output in high-impact journals, with a clear focus on cost-effectiveness analyses of interventions for neglected diseases and healthcare delivery improvements in diverse settings. Dr. Ivashikina has secured substantial research funding from NIHR, European Commission, and other sources for projects including the NIHR Brighton and Sussex Centre for Global Health Research (2021-2026), a study on self-neglect (2022-2024), and the RISEinFAMILY neonatal care project (2021-2025). Her research has significant policy implications, with several studies referenced in policy documents and picked up by news outlets. She leads the postgraduate module on Economic Evaluation in Health Care and supervises undergraduate medical students, MSc students, and PhD candidates. Her teaching emphasizes practical applications of health economics in global health contexts, and she has developed curriculum for both undergraduate and postgraduate programs throughout her career.

• Global Mental Health
• Neglected Tropical Diseases
• Stigma Reduction
• +5 more

Dr. Maya Semrau is a Senior Research Fellow in Implementation Research at Brighton and Sussex Medical School (BSMS), University of Sussex, specializing in global mental health within Neglected Tropical Disease contexts. Her work integrates physical health, mental health, and psychosocial care for people affected by podoconiosis, lymphatic filariasis, and leprosy in Ethiopia, with strong emphasis on stigma reduction and humanitarian emergency response. Her educational background includes: PhD, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London (with WHO) MSc in Mental Health Service and Population Research, IoPPN, King's College London MSc in Experimental Psychology, University of Sussex BSc Honours in Human Sciences, University of Sussex Dr. Semrau's research centers on implementation science to address mental health needs in resource-limited settings, particularly through the development of the HESPER Scale for humanitarian emergencies and integration of mental health into NTD programs. Her work consistently emphasizes community involvement, capacity building, and evidence-based policy development across multiple international projects. Her publication record (2011-2019) reveals persistent focus on mental health systems strengthening in LMICs, stigma reduction, and physical-mental health integration for NTD-affected populations. She employs diverse methodologies including scale development, cross-sectional studies, systematic reviews, and implementation trials to address real-world health challenges. Dr. Semrau actively supervises PhD and MSc students at BSMS and teaches on the MSc in Global Health program. She currently leads the EnDPoINT Consortium and IMPRESS project funded by the NIHR Global Health Research Unit on NTDs, with additional involvement in WHO guideline development and the NTD NGO Network's Mental Wellbeing and Stigma Working Group. Her collaborative work spans the Emerald programme across six LMICs, the INDIGO Partnership in five countries, and multiple WHO initiatives, demonstrating extensive international engagement in mental health and NTD research through coordinated multicountry efforts.

Heather HimburgView profile

Professor

• Radiation Biology
• Cancer Stem Cell Biology
• Hematopoiesis
• +2 more

Heather Himburg, PhD, serves as Professor in the Department of Radiation Oncology at the Medical College of Wisconsin (MCW), where her research focuses on radiation biology and therapeutic development for radiation injury mitigation. Her work bridges translational science and clinical applications in radiation oncology. Education: PhD in Biomedical Engineering, Duke University, 2005 MS in Biomedical Engineering, Ohio State University, 2001 BS in Physics, Miami University, 1998 Research Focus: Dr. Himburg's laboratory investigates acute and delayed radiation effects on multiple organ systems, with specialization in vascular injury mechanisms and bone marrow microenvironment dynamics. Her team develops countermeasures for hematopoietic acute radiation syndrome and studies cancer stem cell biology to improve radiation therapy safety. Current projects target radioprotective therapeutics for bone marrow, heart, lung, and kidney tissues using preclinical models established by MCW emeritus researchers Meetha Medhora and John Moulder. Publication Analysis: Her 2024-2025 publications reveal dominant themes in head and neck cancer therapeutics, radiation-induced organ toxicity, and immune modulation. Key trends include molecular radiosensitization strategies (CXCL12 pathways), advanced imaging for treatment response monitoring, and novel countermeasures for radiation syndromes. The work consistently integrates translational approaches from in vitro models to rodent studies, emphasizing clinical applicability in radiation oncology. Laboratory Structure: The Himburg Laboratory (MFRC 4072/4004 lab, 4076 office) operates as a collaborative hub with Brian Fish directing the Precision Irradiation Core. The team comprises research scientists, technologists, and coordinators specializing in vascular biology, stem cell assays, and radiation countermeasure development, supporting MCW's radiation oncology research infrastructure through the ROCKET Program.

Isabelle BrunetView profile

Researcher

• Neurovascular Interactions
• Neuroscience
• Vascular Biology
• +3 more

Isabelle Brunet is a leading neuroscientist and vascular biologist holding a permanent Inserm research position (ranked 1st) at the Interdisciplinary Center for Research in Biology (CIRB) of the Collège de France in Paris. She directs an 8-member research team investigating neurovascular interactions in development and disease using transgenic mouse/fish models, molecular approaches, and 3D-imaging techniques. Her educational foundation includes a PhD in neuroscience under Alain Prochiantz and Christine Holt focusing on axon guidance in the visual system, followed by postdoctoral training with Anne Eichmann in vascular biology and angiogenesis. This dual expertise enables her unique perspective on neurovascular crosstalk. Brunet's research centers on deciphering how neuronal and vascular systems interact during development and in pathological conditions. Her work explores guidance mechanisms (e.g., Ephrin-A4/EphA4, Netrin-1), arterial innervation dynamics, and lymphatic-vascular interactions, with significant implications for understanding chemotherapy-induced neuropathies and vascular disorders. She employs cutting-edge methodologies including tissue-clearing 3D imaging and functional assays to visualize neurovascular interfaces at cellular resolution. Analysis of her 2014-2022 publications reveals consistent advancement in understanding neurovascular patterning, with particular emphasis on sympathetic innervation of arteries, perivascular macrophage heterogeneity, and Schwann cell-vascular interactions. Her work bridges fundamental developmental biology with translational applications in neuropathic pain and vascular pathologies. Brunet actively contributes to scientific governance through evaluations for Inserm CSS, HCERES, Doctoral Schools, and journal/grant reviews. Her leadership extends to mentoring her research team and disseminating findings through publications and presentations. The Molecular Control of Neurovascular Development laboratory at CIRB operates as a dynamic interdisciplinary hub where neuroscientists, vascular biologists, and imaging specialists collaborate using transgenic models and advanced microscopy to unravel neurovascular communication mechanisms. Current projects focus on functional consequences of neurovascular mispatterning in disease contexts.

Alpaslan TasdoganView profile

Professor

• Cancer Metabolism
• Tumor Metastasis
• Stem Cell Biology
• +4 more

Professor Alpaslan Tasdogan leads the Tumor Metabolism Group at the Institute for Tumor Metabolism, Clinic and Polyclinic for Dermatology, Allergology and Venereology at University Hospital Essen, which is part of the University of Duisburg-Essen's Faculty of Medicine. His research focuses on cancer cell metabolism , particularly the metabolic changes that occur during tumor metastasis and in stem cells. The Tumor Metabolism Group investigates how cancer cells adapt their metabolism to survive the complex process of metastasis, with special attention to hematopoietic stem cells where metabolic processes are tightly regulated during regeneration. The group employs modern mass spectrometry techniques and stable isotope-labeled nutrients to precisely analyze cellular metabolism and metabolic flux within cells. Their research spans multiple cancer types with emphasis on melanoma and stem cell metabolism. Analysis of Dr. Tasdogan's publication record reveals a strong focus on tumor metabolism , metastasis mechanisms , and stem cell biology . His recent work spans diverse areas including purine synthesis in tumors, intestinal stem cell regulation via polyamines, and lymphatic protection of metastasizing melanoma cells from ferroptosis. His research demonstrates significant interdisciplinary collaboration, with publications appearing in top journals including Nature , Cell , and Science , often in collaboration with prominent researchers like Morrison SJ and Schadendorf D. The Tumor Metabolism Group's ultimate goal is to gain significant new insights into metastasis to identify metabolic adaptations, with plans to apply their metabolic testing methods to other cancer types and stem cells to examine the transferability of their findings.

• Infectious Diseases
• Tropical Medicine
• Malaria
• +4 more

Prof. Dr. Achim Hörauf serves as Professor at the University of Bonn's Faculty of Medicine and holds dual leadership roles as Deputy Partner Site Speaker for the Bonn-Köln site and Deputy Coordinator for Malaria and Neglected Tropical Diseases at the German Center for Infection Research (DZIF). His research focuses on developing novel antibiotics targeting Wolbachia endosymbionts in filarial parasites, with significant work on Corallopyronin A for river blindness treatment. Hörauf's research spans Infectious Diseases, Tropical Medicine, and Antibiotics Development, emphasizing macrofilaricidal agents against Onchocerca volvulus. His team investigates immune responses in filariasis, pneumococcal vaccination in immunocompromised patients, and lymphatic pathology mechanisms. Key contributions include advancing Corallopyronin A through preclinical development and establishing diagnostic protocols for onchocerciasis vector surveillance. Analysis of his 15 most recent publications (2022-2024) reveals three dominant research thrusts: 1) Anti-Wolbachial drug development (Corallopyronin A, Muraymycin D2), 2) Immunological profiling of filarial infections (T-cell exhaustion, IgG glycosylation patterns), and 3) Epidemiological studies of neglected tropical diseases (lymphedema microbiology, epilepsy comorbidity). This work bridges basic microbiology with clinical applications for river blindness and lymphatic filariasis. While specific advisees and grant details aren't provided in source materials, Hörauf's DZIF leadership roles indicate active mentorship within the Bonn-Köln research consortium. His work receives institutional support through University Hospital Bonn's tropical medicine infrastructure. Hörauf directs research teams at the DZIF Partner Site Bonn-Köln, collaborating with University Hospital Bonn's tropical medicine division. His laboratory focuses on Wolbachia-targeted therapies and immunological diagnostics for filarial diseases, maintaining active projects on macrofilaricidal drug development and field epidemiology in endemic regions.

Eva LiebauView profile

Professor

• Glutathione metabolism
• Oxidative stress response
• Parasitic nematodes
• +5 more

Prof. Dr. Eva Liebau is a Professor and Group Leader at the Institute for Integrative Cell Biology and Physiology, University of Münster, Germany, specializing in Molecular Physiology. She leads an active research group investigating glutathione metabolism, oxidative stress response, and parasitic nematodes, with significant involvement in the SãMBio German-Brazilian double degree program with the University of São Paulo. Her research focuses on the molecular mechanisms of genetic adaptation to xenobiotic compounds and oxidative stressors, using Caenorhabditis elegans as a model organism. Her work spans environmental stress response, thiol-based redox signaling, glutathione-related enzymes, regulation of translation, and the secretome of parasitic nematodes. She has made significant contributions to understanding the UFM1 cascade, a posttranslational modification system highly conserved in multicellular organisms. Prof. Liebau's recent publications reveal a strong trend toward anthelmintic drug discovery using natural compounds and plant extracts, with particular emphasis on understanding the mechanisms of action against parasitic nematodes. Her work bridges basic molecular research with applied parasitology, contributing to both fundamental understanding of stress responses and potential therapeutic applications. She actively supervises PhD and MSc students including Emma Schröder and Luka Ressmann, and collaborates extensively with international partners including the Institute of Biomedical Sciences at the University of São Paulo, the Institute of Pharmaceutical Biology and Phytochemistry at the University of Münster, and the Redox Homeostasis Group at the Institute of Biomedicine of Seville. Prof. Liebau is affiliated with multiple research networks including Cells in Motion, CRC 1009 (Breaking Barriers), CRC 1348 (Dynamic Cellular Interfaces), CRC 1459 (Intelligent Matter), and CRC 944 (Physiology and Dynamics of Cellular Microcompartments), and participates in several PhD programs including CiM-IMPRS, IRTG Graduate School, and SP BioSciences.

• Physical Medicine and Rehabilitation
• Osteoporosis
• Joint Hypermobility and Ehlers-Danlos Syndrome
• +7 more

Derya DEMİRBAĞ KABAYEL is a Professor at Trakya University Medical Faculty, Department of Physical Medicine and Rehabilitation since 2015. She holds a Doctoral degree obtained in 2003 and has established herself as a prominent researcher in rehabilitation medicine with a focus on multiple specialized areas. Her primary research interests include: Physical Medicine and Rehabilitation protocols Osteoporosis and bone mineral density assessment Joint hypermobility and Ehlers-Danlos Syndrome Parkinson's Disease rehabilitation Pulmonary rehabilitation, particularly related to post-COVID-19 recovery Cardiac rehabilitation and exercise physiology Her publication record demonstrates expertise in developing rehabilitation guidelines, particularly for post-COVID-19 patients, with numerous articles addressing pulmonary rehabilitation principles for acute, subacute, and long-term recovery phases. Her work on Parkinson's rehabilitation compares different exercise modalities including cycle ergometry versus body weight-supported treadmill training. Her research on joint hypermobility spans genetic factors, cardiovascular associations like mitral valve prolapse, and potential biomarkers for Ehlers-Danlos Syndromes. She has also contributed significantly to understanding the relationship between exercise capacity and psychological factors in cardiac rehabilitation. Professor Kabayel has served as a referee for multiple prestigious journals including Turkish Journal of Physical Medicine and Rehabilitation, Archives of Rheumatology, and Balkan Medical Journal. She has participated extensively in national and international conferences, often as a speaker, session chair, or course instructor on topics ranging from lymphedema management to cardiac rehabilitation for spinal cord injury patients. She has advised doctoral dissertations focusing on Parkinson's disease rehabilitation approaches and has participated in various research projects examining multifidus muscle relationships with postural sway, Parkinson's rehabilitation, and gene expression in joint hypermobility cases.

Eva Sevick-MuracaView profile

Professor

• Molecular Imaging
• Near-infrared fluorescence optical imaging
• Tomography
• +5 more

Dr. Eva Sevick-Muraca is a Professor and the Nancy and Rich Kinder Distinguished Chair of Cardiovascular Disease Research at the University of Texas Health Science Center's Institute of Molecular Medicine (IMM), where she directs the Center for Molecular Imaging. She also leads the National Cancer Institute Center for Translational Research at the IMM, focusing on the development and validation of new imaging instrumentation, algorithms, and imaging agents for clinical translation. Dr. Sevick-Muraca's research expertise spans multiple cutting-edge areas in biomedical imaging: Pioneering development of near-infrared fluorescence optical imaging and tomography Diagnostic imaging of lymphatic function Nodal staging in cancer Preclinical small animal imaging with nuclear and optical techniques Clinical translation of imaging technologies Cardiovascular disease imaging applications Her scientific achievements have been recognized with prestigious awards: National Science Foundation Young Investigator Award National Institutes of Health Research Career Award American Cancer Society Research Scholar Award Dr. Sevick-Muraca has built a distinguished career across multiple institutions, having held faculty positions at Vanderbilt University, Purdue University, Texas A&M University, and Baylor College of Medicine before joining the University of Texas Health Science Center. She has contributed significantly to the scientific community through service roles including membership on the Biomedical Imaging Study section, associate editorship of IEEE Transactions of Medical Imaging, and leadership positions in the Society of Molecular Imaging. Her educational foundation includes a Ph.D. in Chemical Engineering from Carnegie Mellon University and post-doctoral training in Biochemistry and Biophysics at the University of Pennsylvania.

Judy L. ThomasView profile

Assistant Clinical Professor

• Physical Medicine and Rehabilitation
• Musculoskeletal Rehabilitation
• Spasticity Management
• +3 more

Dr. Judy L. Thomas is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation (PM&R) at McGovern Medical School, part of The University of Texas Health Science Center at Houston (UTHealth). She serves as Chief of PM&R at Lyndon Baines Johnson General Hospital, a position she has held since 2011 when she joined the UTHealth faculty. Dr. Thomas earned her medical degree from the University of Toronto in 2004, completed residency training in PM&R at McMaster University in 2009, and finished a fellowship in Brain Injury and Spasticity Management at Baylor College of Medicine in 2011. Her clinical expertise spans General Physiatry with special interests in Musculoskeletal Rehabilitation and Spasticity Management. Her research has evolved significantly over the past decade, with recent focus on meningeal lymphatic system function and its relationship to neurological conditions. Dr. Thomas has made important contributions to understanding how lymphatic drainage affects neuroinflammation, brain tumor immunosurveillance, and neural repair processes. Her work bridges clinical rehabilitation medicine with cutting-edge neuroscience and immunology research. Analysis of her publication record from 2010-2024 shows a progression from clinical guidelines in physical medicine to sophisticated investigations of the meningeal lymphatic system. Her most recent work (2023-2024) explores specialized lymphatic circuits including ocular systems and CSF-to-dura gateways, demonstrating increasing specialization in neurolymphatic interactions. Dr. Thomas maintains an active research program with multiple publications in high-impact journals including Nature, Immunity, and Journal of Experimental Medicine. Her collaborative approach is evident in her numerous co-authorships with researchers across disciplines including neuroscience, immunology, and vascular biology. As both a clinician and researcher, Dr. Thomas provides valuable mentorship opportunities for students interested in translational research at the intersection of rehabilitation medicine, neurology, and immunology. Her dual roles enable her to connect basic science discoveries with clinical applications in patient care.

Andreas G. SchreyerView profile

Professor

• Radiology
• Diagnostic Imaging
• Interventional Radiology
• +5 more

Prof. Dr. med. Andreas G. Schreyer serves as Professor of Radiology and Institute Director and Chief Physician at the Institute for Diagnostic and Interventional Radiology, University Hospital Brandenburg an der Havel, part of the Brandenburg Medical School (MHB). His clinical expertise spans diagnostic and interventional radiology with a specialized focus on abdominal imaging. Prof. Schreyer's research interests center on pancreatitis imaging, diverticular disease, inflammatory bowel disease assessment, and patient-centered approaches in radiology. He has made significant contributions to clinical guidelines including the German-language terminology of the revised Atlanta classification for acute pancreatitis and the S2k Guidelines for Diverticular Disease and Diverticulitis. His work bridges radiology with gastroenterology and surgery through multidisciplinary collaboration. His recent publications (2021-2025) demonstrate consistent scholarly output with emphasis on guideline development, pancreatitis imaging, and patient-centered radiology approaches. His work appears in leading German radiology journals including Rofo and Radiologie (Heidelb), with some international publications in the United European Gastroenterology Journal. Prof. Schreyer has contributed to important research on structural and process data for radiological imaging in trauma centers across Germany, abdominal lymphatic malformations, and the differentiation between autoimmune pancreatitis and pancreatic cancer. His research portfolio reflects a commitment to improving diagnostic accuracy and clinical decision-making through advanced imaging techniques.

Falk SchneiderView profile

Assistant Professor

• Fluorescence Microscopy
• Membrane Dynamics
• Biophysics
• +4 more

Falk Schneider is an Assistant Professor at the University of Warwick, where since March 2025 he leads the Fluorescence and Membrane Dynamics (FMD) Lab. He is part of the Centre for Mechanochemical Cell Biology (CMCB) and the Cellular Interfaces Cluster, bringing together cell biologists, developmental biologists, and microscopists to understand membrane organization in fundamental biological processes. Dr. Schneider completed his Bachelor and Master studies in Biochemistry at Leibniz University in Hanover, Germany, beginning his scientific journey in 2010. He earned his PhD at the University of Oxford in the Eggeling Lab, which he joined in October 2015 and defended in January 2020. Following his PhD, he conducted postdoctoral work at the Fritzsche Lab for Biophysical Immunology at the University of Oxford and later at Scott Fraser's lab in the Translational Imaging Center at the University of Southern California (USC). His research centers on the development, advancement, and application of fluorescence microscopy and spectroscopy methods to quantitatively study cellular and sub-cellular dynamics. Dr. Schneider specializes in fluorescence fluctuation spectroscopy (FFS), particularly fluorescence correlation spectroscopy (FCS) in conjunction with super-resolution stimulated emission depletion (STED) microscopy. His work focuses on plasma membrane organization and signaling, biophysical imaging with smart probes like the Flipper tension probe, and computational simulations and data analysis using open-source Python programming. A significant portion of his recent work involves studying molecular interactions in physiological contexts using zebrafish as a model system. His publication record demonstrates expertise in quantifying biomolecular organization in membranes, with recent work on brightness-transit statistics (BTS) methodology that simultaneously measures diffusion dynamics and oligomerization. His research bridges advanced imaging techniques with fundamental biological questions about membrane organization in immune cells and developmental processes. Dr. Schneider has established strong technical expertise in both in vitro model membrane systems and in vivo applications, with a particular focus on making advanced quantitative imaging techniques more accessible to the broader research community through open-source software development and methodological tutorials.